Finance

Lists
INKT:NASDAQ
Mink Therapeutics Inc
USD 12,00
0,00%
(0,00) 1D
11 Sep., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for INKT...
Open
USD 12,17
High
USD 12,48
Low
USD 11,90
Mkt. cap
61,24 m
Avg. vol.
9,07 k
Volume
42,35 k
52-wk high
USD 16,93
52-wk low
USD 8,48
EPS
-USD 2,40
Beta
0,49
Shares outstanding
5,10 m
No. of employees
15
Open
USD 12,17
High
USD 12,48
Low
USD 11,90
Mkt. cap
61,24 m
Avg. vol.
9,07 k
Volume
42,35 k
52-wk high
USD 16,93
52-wk low
USD 8,48
EPS
-USD 2,40
Beta
0,49
Shares outstanding
5,10 m
No. of employees
15
About Mink Therapeutics Inc
CEO-
Employees15
Founded2017
Headquarters-
Sector-
Websiteminktherapeutics.com
Analyst ratings
Based on 1 analyst giving stock ratings to INKT in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for INKT in the last 3 months
Highest
Current USD 12,00
USD 35,00 (+191,67%)
Average
USD 35,00 (+191,67%)
Lowest
USD 35,00 (+191,67%)
Analyst
Recommendation
Action
Price target
Projected
Date
Emily Bodnar
H.C. Wainwright
Buy
Reiterated
USD 35,00
+191,7%
08/14/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1,14 m
1,51 m
1,20 m
1,89 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,85 m
1,76 m
1,68 m
1,33 m
Operating expense
3,18 m
2,71 m
2,88 m
3,22 m
Total operating expenses
3,18 m
2,71 m
2,88 m
3,22 m
Operating income
-3,18 m
-2,71 m
-2,88 m
-3,22 m
Other non operating income
240,73 k
-7,87 k
58,58 k
-
EBT including unusual items
-2,89 m
-2,60 m
-2,74 m
-3,13 m
EBT excluding unusual items
-2,89 m
-2,60 m
-2,74 m
-3,13 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
193,92 k
-571,10 k
-
-
Net income
-2,89 m
-2,60 m
-2,74 m
-3,13 m
Net profit margin
-
-
-
-
Earnings per share
-0,65
-0,56
-0,57
-0,62
Interest and investment income
55,15 k
111,23 k
80,83 k
72,88 k
Interest expense
-
-
-
-
Net interest expenses
55,15 k
111,23 k
80,83 k
72,88 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-3,14 m
-2,67 m
-2,85 m
-3,18 m
Gain or loss from assets sale
2,19 k
509,00
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme